Panobinostat is a novel HDAC inhibitor that inhibits ESCC cell proliferation mainly by significantly inhibiting TP53 expression while increasing p21 and decreasing cell cycle arrest induced by cyclin D1 expression [162]. The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.